Stock Market

Stocks making the biggest moves midday: Snap, Apple, Boeing and more

In this article

Check out the companies making headlines in midday trading.

An Apple store on Nanjing Road Pedestrian Street in Shanghai, China, on December 16, 2022.
CFOTO | Future Publishing | Getty Images

Snap — The tech company’s shares gained almost 13%, having their strongest day since November. Shares gained as U.S. lawmakers prepare legislation that would give President Joe Biden the authority to ban TikTok, one of Snapchat’s primary competitors.

Apple — Shares advanced more than 3% after Goldman Sachs initiated coverage of the big technology stock as a buy. The firm said Apple could get boosted by its services business.

Credit Suisse — Shares were down about 1% after former top shareholder Harris Associates sold its entire stake in Credit Suisse, according to a Financial Times report. Harris Associates CIO David Herro said there are questions about the future of the franchise and large outflows from its wealth management division.

Boeing — The aerospace company’s shares fell 1.6% following reports that software issues could delay deliveries of its MAX and 787 aircraft by up to a year.

RH — The furniture store, formerly known as Restoration Hardware, saw its stock dip more than 2% after Jefferies downgraded it to hold from buy. The Wall Street firm said the luxury housing market is struggling to stabilize, which will impact RH’s business.

Biomarin Pharmaceutical — Shares dropped by more than 6% after competitor BridgeBio Pharma reported positive trial data on its candidate for achondroplasia, the most common form of dwarfism, in children, which could challenge Biomarin’s Voxzogo medication. 

Emerson Electric — Shares rose about 3% following an upgrade by UBS to buy from neutral. The Wall Street firm said the derating of Emerson Electric is overdone.

Vir Biotechnology — The biotech stock added 1.4% following a JPMorgan upgrade to overweight from neutral. The firm said the company has a strong drug pipeline, specifically mentioning its trials for hepatitis B and the flu.

Domino’s Pizza — Domino’s Pizza shares advanced more than 4%. On Friday, Gordon Haskett downgraded the stock to hold from buy, and lowered its price target, saying the pizza chain will find it difficult to “easily drive a return to 6-10% average annual system sales growth.”

— CNBC’s Alex Harring, Yun Li, Sarah Min and Michelle Fox contributed reporting.

Articles You May Like

How activist Irenic can amicably build shareholder value at Reservoir Media
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
Cleveland returns to market with GO, water revenue bond deals
Israel sends thousands more troops into Lebanon
Munis, USTs extend selloff